Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CaRi-Heart® Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA): A Prospective U.S. Community-Based Study on the Impact of CaRi-Heart® Analysis in Patients Undergoing CCTA for Coronary Artery Disease

NCT07220304 is registered in ClinicalTrials.gov with Corazon Medical PC as lead sponsor.

NCT NCT07220304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07220304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CaRi-Heart® Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA): A Prospective U.S. Community-Based Study on the Impact of CaRi-Heart® Analysis in Patients Undergoing CCTA for Coronary Artery Disease
Lead sponsor
Corazon Medical PC
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2025
Completion date
July 31, 2028
Enrollment
15,000 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, cardiovascular inflammation, coronary artery disease